Supplements · Diets
exogenous ketones inhibits NLRP3 inflammasome
In plain terms: Do ketones switch off NLRP3, a key inflammation trigger?
Part of: 🧪 exogenous ketones
Yes for the acid form, but only shown in cells and mice — and the salt sold in supplements appears inert.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: ()
How the studies fall
What the evidence shows
BHB inhibits the NLRP3 inflammasome - but only the protonated ACID form; sodium-BHB (ketone salt) appears inert unless the medium is acidified. In-vitro only; no human supplement trial. Substantially undercuts the popular 'anti-inflammatory ketone salts' marketing.
The evidence (24)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Li Y et al 2026 · study_type: mechanism | observational | supports | low | Review states ketone bodies confer cardioprotection via histone Kbhb, NLRP3 inflammasome suppression, and GPR109A activation in cardiac hypertrophy/heart failure. |
| Deora 2017 · J Neuroimmune Pharmacol | in-vitro | mixed | moderate | BHB blocked ATP/MSU microglial inflammasome but NOT synuclein-fibril NLRP3; activator-specific |
| Gentili V et al 2024 · study_type: in-vitro | in-vitro | supports | moderate | Human HMC3 microglia + novel ketone diester DAG-MAG-BHB: inhibited NLRP3 inflammasome activation under low-glucose/beta-amyloid stress, preserved viability/ATP. |
| Bai 2025 2025 · Redox Biol | animal | supports | moderate | [FT-verified] BHB ameliorates LPS liver injury via inflammasome inhibition (rodent); form-agnostic |
| Zhang 2025 · Food & Function | animal | supports | moderate | Ketogenic diet inhibits microglial NLRP3 in EAE via HDAC3/mitophagy, reducing demyelination |
| Parveen 2025 · Mol Neurobiol | animal | supports | moderate | KD inhibits TXNIP/NLRP3 via HIF-1a/IL-10 in mouse stroke; no neuroprotection in NLRP3-KO (dependence) |
| Fastiggi VA et al 2026 · study_type: in-vitro | in-vitro | mixed | moderate | Human bronchial smooth muscle cells + mouse lung slices: BHB suppressed IL-1B-induced cytokine production and contraction via FFAR3, not stated as NLRP3-mediated. |
| Luo Y et al 2026 · study_type: animal | animal | mixed | low | Mouse AIT model: ketogenic diet (endogenous ketosis) suppressed NLRP3/ASC/Caspase-1 gene expression and HMGB1/NLRP3 signaling, reduced IL-1B and other cytokines. |
| Mank MM et al] # corrected 2026-08-17 from PubMed; was [(NLRP3 in-vitro) 2026 · (in-vitro) | in-vitro | supports | high | NaBHB inert; only acid BHBA inhibits NLRP3 in mouse macrophages+human PBMC; FFAR3 enhances |
| Yang W et al 2025 · study_type: mechanism | observational | supports | low | PCOS review: states BHB 'directly suppresses' the NLRP3 inflammasome as one of several anti-inflammatory mechanisms of ketogenic diet. |
| Sander NH et al 2024 · study_type: animal | animal | supports | low | Rat intracerebral hemorrhage model: subQ BHB (250mg/kg, likely acid/free-acid form) reduced Il1b/Tnfa/Mcp1 transcripts at day 3, but no lasting neuroprotection or reduced lesion volume. |
| Wang P et al 2026 · study_type: animal | animal | mixed | low | Rat cardiac-arrest model: BHB treatment (form unspecified) reduced serum/brain TNF-a and IL-1B alongside neuroprotection; NLRP3 not directly assayed. |
| Ari C et al 2025 · study_type: animal | animal | tested-null | low | Chronic rat study: ketone SALTS (KS) preserved liver histology/lower TNF-a, while ketone ester (KE) and precursor (BD) caused steatosis/inflammation; NLRP3 not assessed. |
| Hirata 2021 · J Reprod Immunol | animal | supports | moderate | BHB suppresses NLRP3-mediated placental IL-1b and LPS-induced fetal absorption in mice + human trophoblast |
| Youm 2015 · Nat Med | in-vitro | supports | moderate | [FT-verified] Youm 2015 NatMed BHB blocks NLRP3 in macrophages/mice; landmark general mechanism |
| Neudorf 2020 · Nutrients | RCT | mixed | moderate | Acute ketone monoester in obese humans lowered ex vivo LPS-stimulated NLRP3/IL-1b (placebo crossover) |
| Zhang 2021 · Adv Sci | animal | supports | moderate | Oral 3-HB ameliorates atherosclerosis via macrophage Gpr109a-mediated effect on NLRP3 inflammation |
| Kim 2020 · Nat Commun | in-vitro | supports | moderate | SGLT2i raises serum BHB and suppresses macrophage NLRP3/IL-1b; high-BHB+low-insulin inhibits ex vivo |
| Goldberg 2017 · Cell Rep | in-vitro | supports | moderate | [FT-verified] Goldberg 2017 BHB deactivates neutrophil NLRP3; no salt-vs-acid distinction |
| Neudorf 2019 · Mol Nutr Food Res | n-of-1 | contradicts | moderate | Oral ketone supplement ACUTELY INCREASED monocyte NLRP3 markers in humans - opposite to cell-culture |
| Shippy 2020 · J Neuroinflammation | animal | supports | moderate | [FT-verified] Shippy 2020 5XFAD mice BHB cut plaque+caspase-1 via NLRP3. ANIMAL |
| Gong Y et al 2026 · study_type: mechanism | observational | supports | low | Review: BHB regulates macrophages/T cells via NLRP3 inflammasome inhibition, HCAR2 activation, histone Kbhb; preclinical/early clinical evidence for autoimmune/inflammatory disease. |
| Shippy 2025 · Immunological Reviews | mechanism | supports | moderate | Review: elevated BHB inhibits microglial NLRP3 activation; ketone therapies proposed for Alzheimer's |
| Nomura M et al 2024 · study_type: in-vitro | in-vitro | supports | moderate | Human/mouse primary microglia: BHB inhibited LPS-induced inflammatory gene expression; authors note 'an acidic milieu resulting from BHB may be required' for the effect. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.